Japanese Pharma Stock News

Mazda Motor Corporation recently unveiled two concept vehicles, the MAZDA VISION X-COUPE and MAZDA VISION X-COMPACT, showcasing innovative hybrid and AI-driven technologies, alongside the European debut of the all-new MAZDA CX-5 featuring advanced vehicle architecture and design. These announcements highlight Mazda's commitment to sustainable mobility and emotional connectivity, blending next-generation powertrains with smart, human-centered technologies. We'll explore how Mazda's...

Nintendo Co., Ltd. ( TSE:7974 ) just released its interim report and things are looking bullish. Nintendo delivered a...

Despite announcing strong earnings, Disco Corporation's ( TSE:6146 ) stock was sluggish. We did some digging and found...

SKY Perfect JSAT Holdings (TSE:9412) is moving forward with a collaborative initiative to launch three satellites in partnership with SpaceX. This step supports the company’s strategy to enhance its satellite communications capabilities and appears to be attracting fresh attention from investors. See our latest analysis for SKY Perfect JSAT Holdings. Investor excitement following the SpaceX collaboration is evident, with SKY Perfect JSAT Holdings posting a stunning 9% share price gain in a...

Mitsui O.S.K. Lines, Ltd. ( TSE:9104 ) shareholders are probably feeling a little disappointed, since its shares fell...

Murata Manufacturing recently completed a share buyback of 42,158,500 shares for ¥99.99 billion and released new consolidated earnings guidance for the fiscal year ending March 31, 2026. This combination of a substantial capital return and updated profit outlook highlights the company's approach to shareholder value and financial planning. We’ll look at how Murata’s major buyback may influence the company’s investment narrative and future capital allocation focus. Trump has pledged to...

Investors were underwhelmed by the solid earnings posted by J-Stream Inc. ( TSE:4308 ) recently. We have done some...

Daiichi Sankyo (TSE:4568) shares drew attention after the company, together with AstraZeneca Canada, secured Health Canada's approval for Enhertu as a treatment for specific advanced breast cancer types. This approval followed strong phase III trial results. See our latest analysis for Daiichi Sankyo Company. This pivotal news comes after a difficult stretch for Daiichi Sankyo’s stock, which has seen its share price drop over 20% year-to-date and a one-year total shareholder return of -28.5%...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Zeon Corporation's ( TSE:4205 ) robust recent earnings didn't do much to move the stock. We think this is due to...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Keyence Corporation announced that its Board of Directors approved executive changes, appointing Tetsuya Nakano as the next President and Representative Director, effective December 22, 2025, and increased its interim and forecasted year-end dividends to JPY 275 per share, with an effective dividend date of November 25, 2025. This dual move highlights Keyence’s drive to both reinforce its management structure and enhance shareholder returns, signaling confidence in its steady earnings...

Mitsubishi Motors (TSE:7211) is expected to shift into profitability within the next three years, outpacing average market growth expectations. Losses have narrowed at an impressive rate of 46.5% per year over the past five years, and earnings are now projected to accelerate by 57.26% per year. With a solid trajectory toward positive net income and revenues set to grow at 3.3% annually, the stage is set for investors to evaluate the balance between swift profit growth and slightly lagging...

Mitsui (TSE:8031) has seen its stock edge higher over the past month, gaining nearly 10%. Investors seem interested in the company’s steady pace, especially given its modest revenue and net income growth for the year. See our latest analysis for Mitsui. Momentum around Mitsui continues to build, with a 23% share price return so far in 2024 and a stellar 27% total shareholder return over the past year. While the stock has attracted fresh attention recently, those who held for the past three or...

Subaru Corporation recently announced a correction to its previously disclosed first-quarter financial results for the fiscal year ending 2026, reducing the profit attributable to owners, and provided an update on its ongoing share repurchase program, having bought back over 4.14 million shares out of a planned maximum of 20.84 million by December 23, 2025. This combination of financial reporting adjustments and capital allocation actions underscores how transparency and shareholder-focused...

Sumitomo Chemical Company, Limited ( TSE:4005 ) shareholders are probably feeling a little disappointed, since its...

It's been a sad week for Hirose Electric Co.,Ltd. ( TSE:6806 ), who've watched their investment drop 13% to JP¥17,550...

On October 30, 2025, Financial Partners Group Co., Ltd. announced a year-end dividend cut to ¥65.20 per share for the fiscal year ended September 30, 2025, down from ¥81.55 a year earlier, and provided further reduced dividend guidance for the next fiscal year along with new consolidated earnings forecasts. This sequence of announcements highlights both a sustained shift in the company’s dividend policy and management’s expectations for performance in the upcoming year. We’ll explore how...

ASKA Pharmaceutical Holdings (TSE:4886) posted a net profit margin of 7.1% for the latest period, down from 9.4% a year earlier, while also recording a one-off gain of ¥1.2 billion ahead of September 2025. Over the last five years, earnings grew at an average rate of 18% annually. However, the most recent year saw a decline, and both earnings and revenue are now forecast to rise at a more modest 2.9% per year, lagging the broader Japanese market’s growth expectations. With a current...

JVCKENWOOD (TSE:6632) just lifted its full-year financial outlook and announced a higher interim dividend for shareholders. The company now anticipates improved revenue and profits for the fiscal year ending March 2026, along with a boost to payouts. See our latest analysis for JVCKENWOOD. Investors have clearly responded to JVCKENWOOD’s brighter earnings guidance and higher dividend, with the share price jumping 21.3% over the last month and notching a 12.8% gain in just the past week. While...

Wondering if Mitsui Kinzoku Company stock is a hidden gem or already fairly priced? You are not alone. In a market full of surprises, getting the value call right can make all the difference. The stock has been on a tear lately, surging 6.0% in the last week, 25.8% over the past month, and posting a staggering 256.9% year-to-date rise. Behind these eye-catching numbers, recent market headlines have highlighted ongoing sector optimism and investor attention on Japanese materials stocks. News...

Central Japan Railway Company announced an increase in its second-quarter-end dividend to ¥16.00 per share for the fiscal year ending March 31, 2026, up from ¥15.00 a year earlier, and also issued new consolidated and nonconsolidated earnings guidance for the same period. This combination of a dividend boost and forward-looking financial projections highlights management’s confidence in the company’s operational outlook and approach to shareholder returns. We’ll explore how Central Japan...

Bridgestone (TSE:5108) shares have shifted slightly in recent trading. Investors may be taking stock of recent performance, as the stock has risen nearly 28% over the past year and year-to-date gains are at a similar level. See our latest analysis for Bridgestone. Bridgestone's momentum has remained strong after last year's rally, with a 27% year-to-date share price return that builds on a robust 28% total shareholder return over the past twelve months. Solid long-term results suggest that...

Nippon Steel (TSE:5401) remains unprofitable, but over the past five years, the company has narrowed its losses at an annual rate of 20.4%. While revenue is forecast to grow at 3.1% per year, trailing the broader Japanese market’s 4.4% projection, earnings are expected to accelerate at 28.94% per year with profitability anticipated within the next three years. Shares are trading at ¥594.6, significantly below an estimated fair value of ¥1,055.76. This has investors weighing the company’s path...